Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

172 та иш

Иш: The Radioprotective Potentials of Silymarin/Silibinin Against Radiotherapy-Induced Toxicities: A Systematic Review of Clinical and ExperimentalStudies

  1. Improved dissolution and bioavailability of silymarin delivered by a solid dispersion prepared using supercritical fluids

    Gang Yang, Yaping Zhao, Nianping Feng +3

    Мақола20144 иқтибос
    ABI

  2. Chemoenzymatic Preparation of Oligoglycosides of Silybin, the Flavonolignan from Silybum marianum

    Vilı́m Šimánek, Jiří Kubisch, Petr Sedmera +4

    Мақола20014 иқтибос
    ABI

  3. Antioxidant properties of silybin glycosides

    Pavel Kosina, Vladim�r K en, Rolf Gebhardt +3

    Мақола20024 иқтибос
    ABI

  4. Toward the Definition of the Mechanism of Action of Silymarin: Activities Related to Cellular Protection From Toxic Damage Induced by Chemotherapy

    Maria Cristina Comelli, U. Mengs, Carl Christoph Schneider +1

    Шарҳ мақола20074 иқтибос
    ABI

  5. Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives

    Peter Surai

    Шарҳ мақола20154 иқтибос
    ABI

  6. Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP

    W. Zhu

    Мақола20014 иқтибос
    ABI

  7. Silybin and Silymarin - New and Emerging Applications in Medicine

    Radek Gažák, Daniela Walterová, Vladimı́r Křen

    Шарҳ мақола20074 иқтибос
    ABI

  8. Flavonolignan 2,3-dehydroderivatives: Preparation, antiradical and cytoprotective activity

    Michaela Pyszková, Michal Biler, David Biedermann +11

    Мақола20154 иқтибос
    ABI

  9. Preparation, Pharmacokinetics and Body Distribution of Silymarin-Loaded Solid Lipid Nanoparticles After Oral Administration

    Jun He, Shi-xiang Hou, Weigen Lu +2

    Мақола20074 иқтибос
    ABI

  10. Silymarin suppressed lung cancer growth in mice via inhibiting myeloid-derived suppressor cells

    Tiancong Wu, Wen Liu, Wenjie Guo +1

    Мақола20164 иқтибос
    ABI

  11. Silymarin for Liver Disease

    Ludovico Abenavoli, Nataša Milić

    Боб20174 иқтибос
    ABI

  12. Flavonolignan 2,3-dehydrosilydianin activates Nrf2 and upregulates NAD(P)H:quinone oxidoreductase 1 in Hepa1c1c7 cells

    Lenka Roubalová, Albena T. Dinkova‐Kostova, David Biedermann +3

    Мақола20174 иқтибос
    ABI

  13. Quality by design based silymarin nanoemulsion for enhancement of oral bioavailability

    Amrita Nagi, Babar Iqbal, Shobhit Kumar +3

    Мақола20174 иқтибос
    ABI

  14. Therapeutic effects of silymarin and naringin on methotrexate-induced nephrotoxicity in rats: Biochemical evaluation of anti-inflammatory, antiapoptotic, and antiautophagic properties

    Fatih Mehmet Kandemır, Sefa Küçükler, Cüneyt Çağlayan +3

    Мақола20174 иқтибос
    ABI

  15. HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity Studies

    Haneen Amawi, Noor Hussein, Chandrabose Karthikeyan +7

    Мақола20174 иқтибос
    ABI

  16. Reduction–oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics

    Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan +8

    Шарҳ мақола20184 иқтибос
    ABI

  17. Effects of Silymarin-Loaded Nanoparticles on HT-29 Human Colon Cancer Cells

    Maryam Mombeini, Ghasem Saki, Layasadat Khorsandi +1

    Мақола20184 иқтибос
    ABI

  18. Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases

    Abdoh Taleb, Khalil Ali Ahmad, Awais Ullah Ihsan +6

    Шарҳ мақола20184 иқтибос
    ABI

  19. Silymarin Nanoformulation as Potential Anticancer Agent in Experimental Ehrlich Ascites Carcinoma-Bearing Animals

    Mohamed El‐Far, Neven Salah, Alaa Essam +2

    Мақола20184 иқтибос
    ABI

  20. Silymarin-laden PVP-PEG polymeric composite for enhanced aqueous solubility and dissolution rate: Preparation and in vitro characterization

    Abid Mehmood Yousaf, Usman Rashid Malik, Yasser Shahzad +2

    Мақола20184 иқтибос
    ABI

  21. Selective Synthesis of 3-O-Palmitoyl-Silybin, a New-to-Nature Flavonolignan with Increased Protective Action against Oxidative Damages in Lipophilic Media

    Samantha Drouet, Joël Doussot, Laurine Garros +6

    Мақола20184 иқтибос
    ABI

  22. Formulation and optimization of lyophilized nanosuspension tablets to improve the physicochemical properties and provide immediate release of silymarin

    Ahmed H. Ibrahim, Emil Rosqvist, Jan‐Henrik Smått +5

    Мақола20194 иқтибос
    ABI

  23. Mesoporous silica nanoparticles, a safe option for silymarin delivery: preparation, characterization, and in vivo evaluation

    Sarah Nasr, Maha M. A. Nasra, Heba A. Hazzah +1

    Мақола20194 иқтибос
    ABI

  24. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review

    Vahid Soleimani, Parisa Sadat Delghandi, Seyed Adel Moallem +1

    Шарҳ мақола20194 иқтибос
    ABI

  25. A pilot study of the UVA-photoprotective potential of dehydrosilybin, isosilybin, silychristin, and silydianin on human dermal fibroblasts

    Alena Rajnochová Svobodová, Eva Gabrielová, Jitka Ulrichová +3

    Мақола20194 иқтибос
    ABI